Immunotherapy Hereditary diffuse gastric cancer spectrum associated with germline CTNNA1 loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls. 2026-04-07 Diffuse gastric cancer (DGC) is the most common manifestation in germline CTNNA1 variant carriers, with one study estimating a 49-57% lifetime risk by age 80….
AI and biotech AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder. 2026-04-14 The opioid epidemic has led to a devastating loss of life nationwide. Of those dependent on opioids, many individuals desire to quit or reduce use, but their efforts are often unsuccessful given the powerful reinforcing properties…
AI and biotech AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder. 2026-04-14 The opioid epidemic has led to a devastating loss of life nationwide. Of those dependent on opioids, many individuals desire to quit or reduce use, but their efforts are often unsuccessful given the powerful reinforcing properties…
📅 2026년 4월 7일 | PubMed 수집 논문 AI and biotech Design and Photophysical Engineering of Functional Organic Luminogens for Precision Cancer Theranostics. 2026-04-05 Cancer remains a significant global health challenge, necessitating innovative therapeutic strategies. Functional organic luminogens have emerged as a versatile class of biomaterials for cancer theranostics, enabling the integration of diagnostic imaging…
📅 2026년 4월 6일 | PubMed 수집 논문 AI and biotech Targeting signaling pathways in lymphoma: From molecular mechanisms to clinical breakthroughs. 2026-04-04 The treatment paradigm for lymphoma, a highly heterogeneous group of hematologic malignancies, has been revolutionized by the development of therapies targeting oncogenic signaling pathways. This shift from conventional chemotherapy to precision medicine…
